Paulson & Co. Buys Anadarko Petroleum Corp, Sothebys, Array BioPharma Inc, Sells SPDR Gold Trust, Bausch Health Inc, Celgene Corp

• New Purchases: APC, BID, ARRY, ONCE, PCG, UTX, SSRM, BKS, ZAYO,
• Added Positions: AGN, PCRX, S,
• Reduced Positions: GLD, BHC, CELG, DISCK, TAK, AABA, AU, DISH, TMUS, RHT, NG, TSU, FDC, VIAB, THM, STC, GOLD, AEM, TRCO, CZR, TMQ, QEP, NMRK, WCG, LEXEA, SA, INSW, IAG, VSM, SD, LEA, SES,
• Sold Out: CNC, TVPT, TVPT, FOX, ULTI, WBC, KMDA, KMDA, ATTU, ATTU, ON, NXPI, NXPI, DIS,

For the details of John Paulson's stock buys and sells, go to https://www.gurufocus.com/guru/john+paulson/current-portfolio/portfolio

1. SPDR Gold Trust (GLD) - 4,320,022 shares, 9.78% of the total portfolio. Shares reduced by 50%
2. Bausch Health Companies Inc (BHC) - 20,839,035 shares, 8.93% of the total portfolio. Shares reduced by 50%
3. Allergan PLC (AGN) - 2,249,500 shares, 6.40% of the total portfolio. Shares added by 45.18%
4. Discovery Inc (DISCK) - 10,922,500 shares, 5.28% of the total portfolio. Shares reduced by 50%
5. Celgene Corp (CELG) - 3,350,000 shares, 5.26% of the total portfolio. Shares reduced by 50%

Paulson & Co. initiated holding in Anadarko Petroleum Corp. The purchase prices were between $44.47 and $75.86, with an estimated average price of $67.07. The stock is now traded at around $72.77. The impact to a portfolio due to this purchase was 5.18%. The holding were 4,320,000 shares as of .

Paulson & Co. initiated holding in Sothebys. The purchase prices were between $32.38 and $59.08, with an estimated average price of $41.74. The stock is now traded at around $58.10. The impact to a portfolio due to this purchase was 3.33%. The holding were 3,367,800 shares as of .

Paulson & Co. initiated holding in Array BioPharma Inc. The purchase prices were between $20.84 and $46.58, with an estimated average price of $27.97. The stock is now traded at around $47.85. The impact to a portfolio due to this purchase was 2.58%. The holding were 3,275,700 shares as of .

Paulson & Co. initiated holding in Spark Therapeutics Inc. The purchase prices were between $97.7 and $114.01, with an estimated average price of $107.99. The stock is now traded at around $99.33. The impact to a portfolio due to this purchase was 1.32%. The holding were 757,807 shares as of .

Paulson & Co. initiated holding in PG&E Corp. The purchase prices were between $17.02 and $23.95, with an estimated average price of $20.09. The stock is now traded at around $14.13. The impact to a portfolio due to this purchase was 1.17%. The holding were 3,000,810 shares as of .

Paulson & Co. initiated holding in United Technologies Corp. The purchase prices were between $122.94 and $142.61, with an estimated average price of $132.92. The stock is now traded at around $123.80. The impact to a portfolio due to this purchase was 0.44%. The holding were 200,000 shares as of .

Paulson & Co. added to a holding in Allergan PLC by 45.18%. The purchase prices were between $115.73 and $167.43, with an estimated average price of $138.45. The stock is now traded at around $156.59. The impact to a portfolio due to this purchase was 1.99%. The holding were 2,249,500 shares as of .

Paulson & Co. added to a holding in Pacira BioSciences Inc by 91.80%. The purchase prices were between $36.57 and $47.97, with an estimated average price of $42.38. The stock is now traded at around $39.04. The impact to a portfolio due to this purchase was 0.34%. The holding were 958,997 shares as of .

Paulson & Co. added to a holding in Sprint Corp by 28.42%. The purchase prices were between $5.48 and $7.45, with an estimated average price of $6.33. The stock is now traded at around $6.83. The impact to a portfolio due to this purchase was 0.2%. The holding were 8,000,000 shares as of .

Paulson & Co. sold out a holding in Centene Corp. The sale prices were between $47.01 and $57.88, with an estimated average price of $53.96.

Paulson & Co. sold out a holding in Travelport Worldwide Ltd. The sale prices were between $14.85 and $15.75, with an estimated average price of $15.56.

Paulson & Co. sold out a holding in Travelport Worldwide Ltd. The sale prices were between $14.85 and $15.75, with an estimated average price of $15.56.

Paulson & Co. sold out a holding in Fox Corp. The sale prices were between $33.68 and $38.74, with an estimated average price of $36.32.

Paulson & Co. sold out a holding in The Ultimate Software Group Inc. The sale prices were between $329.94 and $331.36, with an estimated average price of $330.68.

Paulson & Co. sold out a holding in WABCO Holdings Inc. The sale prices were between $130.26 and $133.6, with an estimated average price of $131.9.

Paulson & Co. reduced to a holding in SPDR Gold Trust by 50%. The sale prices were between $119.94 and $134.2, with an estimated average price of $123.59. The stock is now traded at around $143.48. The impact to a portfolio due to this sale was -5.64%. Paulson & Co. still held 4,320,022 shares as of .

Paulson & Co. reduced to a holding in Bausch Health Companies Inc by 50%. The sale prices were between $20.52 and $26.45, with an estimated average price of $23.73. The stock is now traded at around $20.76. The impact to a portfolio due to this sale was -5.51%. Paulson & Co. still held 20,839,035 shares as of .

Paulson & Co. reduced to a holding in Celgene Corp by 50%. The sale prices were between $92.35 and $98.91, with an estimated average price of $94.95. The stock is now traded at around $93.21. The impact to a portfolio due to this sale was -3.38%. Paulson & Co. still held 3,350,000 shares as of .

Paulson & Co. reduced to a holding in Discovery Inc by 50%. The sale prices were between $25.48 and $29.49, with an estimated average price of $27.13. The stock is now traded at around $25.09. The impact to a portfolio due to this sale was -2.97%. Paulson & Co. still held 10,922,500 shares as of .

Paulson & Co. reduced to a holding in Takeda Pharmaceutical Co Ltd by 50%. The sale prices were between $16.58 and $20.49, with an estimated average price of $18.19. The stock is now traded at around $16.82. The impact to a portfolio due to this sale was -2.89%. Paulson & Co. still held 13,244,711 shares as of .

Paulson & Co. reduced to a holding in Altaba Inc by 60.12%. The sale prices were between $59.2 and $79.15, with an estimated average price of $69.95. The stock is now traded at around $69.92. The impact to a portfolio due to this sale was -2.27%. Paulson & Co. still held 1,900,163 shares as of .